Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Privia Health (PRVA) EBITDA (2020 - 2025)

Historic EBITDA for Privia Health (PRVA) over the last 6 years, with Q3 2025 value amounting to $14.6 million.

  • Privia Health's EBITDA rose 13866.32% to $14.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.0 million, marking a year-over-year increase of 10251.99%. This contributed to the annual value of $18.1 million for FY2024, which is 1712.41% down from last year.
  • According to the latest figures from Q3 2025, Privia Health's EBITDA is $14.6 million, which was up 13866.32% from $3.5 million recorded in Q2 2025.
  • In the past 5 years, Privia Health's EBITDA registered a high of $14.6 million during Q3 2025, and its lowest value of -$192.9 million during Q2 2021.
  • For the 5-year period, Privia Health's EBITDA averaged around -$9.0 million, with its median value being $3.5 million (2025).
  • Its EBITDA has fluctuated over the past 5 years, first tumbled by 301754.39% in 2021, then soared by 38755.6% in 2025.
  • Over the past 5 years, Privia Health's EBITDA (Quarter) stood at -$19.1 million in 2021, then surged by 113.33% to $2.5 million in 2022, then crashed by 32.49% to $1.7 million in 2023, then soared by 219.11% to $5.5 million in 2024, then skyrocketed by 166.03% to $14.6 million in 2025.
  • Its EBITDA was $14.6 million in Q3 2025, compared to $3.5 million in Q2 2025 and $5.4 million in Q1 2025.